Skip to content
Unrated Drug recall · FDA · Published January 30, 2025

Potassium Chloride Extended-Release Tablets Recall: Failed Dissolution Specifications

Major Pharmaceuticals recalls Potassium Chloride Extended-Release Tablets due to failed dissolution specifications. This could affect medication effectiveness. Check your product details and contact the manufacturer for instructions.

🇺🇸 FDA recall #D-0221-2025DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

What happened, in plain English

Major Pharmaceuticals is recalling Potassium Chloride Extended-Release Tablets because they failed dissolution specifications. This means the tablets may not release potassium chloride properly, potentially affecting medication effectiveness. Consumers should check their product details and contact the manufacturer for instructions. Read more at govinfonow.com/recall/32301-potassium-chloride-extended-release-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/32301-potassium-chloride-extended-release-tablets-recall-failed-dissolution-specifications · Updated August 17, 2026 · FDA enforcement record: FDA #D-0221-2025

Cite this page

“Potassium Chloride Extended-Release Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32301-potassium-chloride-extended-release-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0221-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0221-2025%22&limit=1).

Why it’s dangerous

The tablets failed dissolution specifications, meaning they may not release potassium chloride as intended. This could lead to improper medication effectiveness. The exact risk level is not clearly described in the recall notice.

Who’s affected

People who have the Potassium Chloride Extended-Release Tablets (10 mEq/750 mg) with NDC 0904-7216-61 and lot number T05224 are affected. Those using these tablets for medical purposes are most at risk.

How to tell if you have this one

Check for the product name 'Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters)'. Look for NDC 0904-7216-61 and lot number T05224 on the packaging.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 0904-7216-61 and lot number T05224 on the packaging to confirm if your product is recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

1. Firm started the recall: Jan 30, 202512. FDA classified it Class II: Feb 4, 202523. Published in FDA’s Enforcement Report: Feb 12, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0221-2025 (January 30, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0221-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA